Relationship Between Subcutaneous Adipose Tissue Expression of Leptin And Obesity in Tunisian Patients

##plugins.themes.academic_pro.article.sidebar##

Published Aug 4, 2010
Download
pdf
Vol. 88 No. 8 (2010): Issue Aug 2010

##plugins.themes.academic_pro.article.main##

Soumaya Kouidhi
Slim Jarboui
Marie-Stéphanie Clerget Froidevaux
Hafawa Abid
Barbara Demeneix
Abdeljélil Zaouche
Amal Benammar Elgaaied
Hajer Guissouma

Abstract

Background : The incidence of obesity has dramatically increased in overall the world. It is a consequence of imbalance between energy intake and energy expenditure. Leptin is a fat derived adipokine that has emerged over the past decade as a key hormone in the regulation of food intake and energy expenditure. Elevated leptin levels are found in obese humans, suggesting a role of leptin in regulating body weight and adiposity.
Aim : The aim of this study was to investigate the change of leptin mRNA expression level and its correlation with obesity and several metabolic variables in Tunisian patients.
Methods: Real time quantitative polymerase chain reaction (QPCR) analysis was carried out among two groups who underwent an abdominal surgery: controls (n=9) and obese patients (n=7).
Results: Leptin mRNA expression in subcutaneous adipose tissue was markedly increased in obese patients (p<0.01). It was positively correlated with measures of obesity waist circumference (WC) (r=0, 71, p<0.01) and body mass index (BMI) (r=0, 68, p<0.01). Interestingly, leptin gene expression was also correlated to insulin resistance index (r=0, 72, p<0.01).
Conclusion: The present study is the first investigation of leptin regulation in subcutaneous adipose tissue of Tunisian population. Our data showed that leptin levels are higher in obese subjects than in control subjects. This indicates that the subcutaneous adipose plays an important role in impaired adipokine regulation, and
consequently in developing metabolic disorder.

Keywords:

Obesity, leptin, subcutaneous adipose tissue, metabolic disorder

##plugins.themes.academic_pro.article.details##

References

  1. Wozniak SE, Gee LL, Wachtel MS, Frezza EE: Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 2009;54:1847-1856.
  2. Trayhurn P, Wood IS: Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005;33:1078-1081.
  3. Phillips LK PJ: The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 2008;10: 156-164.
  4. Rasouli N, Kern PA: Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008;93:S64- 73.
  5. Phillips L, Prins J: The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 2008;10: 156-164..
  6. Coppack SW: Adipose tissue changes in obesity. Biochem Soc Trans 2005;33:1049-1052.
  7. Korner J, Woods SC, Woodworth KA: Regulation of energy homeostasis and health consequences in obesity. Am J Med 2009;122:S12-18.
  8. Mor G, Visintin I, Lai Y, Zhao H, Schwartz P, Rutherford T, Yue L, Bray-Ward P, Ward DC: Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci U S A 2005;102:7677-7682.
  9. Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, Yu JC, Sun CA: Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer 2009;100:578-582.
  10. Jaffe T, Schwartz B: Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signaltransduction pathways. Int J Cancer 2008;123:2543-2556.
  11. Friedman JM: Leptin at 14 y of age: an ongoing story. Am J Clin Nutr 2009;89:973S-979S.
  12. Farooqi IS, O'Rahilly S: Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009;89:980S-984S.
  13. Bluher S, Mantzoros CS: Leptin in humans: lessons from translational research. Am J Clin Nutr 2009;89:991S-997S.
  14. Thorburn AW, Holdsworth A, Proietto J, Morahan G: Differential and genetically separable associations of leptin with obesityrelated traits. Int J Obes Relat Metab Disord 2000;24:742-750.
  15. Mantzoros CS: The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999;130:671-680.
  16. Maes HH, Neale MC, Eaves LJ: Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997;27:325-351.
  17. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770.
  18. Almanza-Perez JC, Blancas-Flores G, Garcia-Macedo R, Alarcon-Aguilar FJ, Cruz M: [Leptin and its association with obesity and type 2 diabetes]. Gac Med Mex 2008;144:535-542.
  19. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB, Sr., O'Donnell CJ: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48.
  20. Sudi KM, Gallistl S, Trobinger M, Weinhandl G, Aigner R, Payerl D, Tafeit E, Moller R, Borkenstein MH: Subcutaneous adipose tissue layers as a stable correlate of leptin in response to short term energy restriction in obese girls. Int J Obes Relat Metab Disord 2001;25 Suppl 1:S43-45.
  21. Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P: Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998;47:913-917.
  22. Lee JH, Reed DR, Price RA: Leptin resistance is associated with extreme obesity and aggregates in families. Int J Obes Relat Metab Disord 2001;25:1471-1473.
  23. Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature 2006;444:881-887.
  24. Hamdy O, Porramatikul S, Al-Ozairi E: Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006;2:367-373.
  25. Atamer A, Alisir Ecder S, Akkus Z, Kocyigit Y, Atamer Y, Ilhan N, Ecder T: Relationship between leptin, insulin resistance, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with chronic kidney disease. J Int Med Res 2008;36:522-528.
  26. Lichnovska R, Gwozdziewiczova S, Chlup R, Hrebicek J: Serum leptin in the development of insulin resistance and other disorders in the metabolic syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005;149:119-126.
  27. Pratley RE, Ren K, Milner MR, Sell SM: Insulin increases leptin mRNA expression in abdominal subcutaneous adipose tissue in humans. Mol Genet Metab 2000;70:19-26.
  28. Brennan AM, Mantzoros CS: Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications. Nat Clin Pract Endocrinol Metab 2006;2:318-327.